APA citiranje

Razak, A. R. A., Hotte, S. J., Siu, L. L., Chen, E. X., Hirte, H. W., Powers, J., . . . Eisenhauer, E. A. (2011). Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours. Nature Publishing Group.

Citação norma Chicago

Razak, A R A., et al. Phase I Clinical, Pharmacokinetic and Pharmacodynamic Study of SB939, an Oral Histone Deacetylase (HDAC) Inhibitor, in Patients With Advanced Solid Tumours. Nature Publishing Group, 2011.

MLA citiranje

Razak, A R A., et al. Phase I Clinical, Pharmacokinetic and Pharmacodynamic Study of SB939, an Oral Histone Deacetylase (HDAC) Inhibitor, in Patients With Advanced Solid Tumours. Nature Publishing Group, 2011.